News und Analysen
NuVasive's Sluggish Sales Growth Prompts Buybacks
Modern medicine has offered some revolutionary products and techniques, and many companies are looking to help sustain the pace of medical advances. NuVasive's (NASDAQ: NUVA) specialty in spinal....
Illumina Inc. Keeps Up Its Winning Ways Thanks to NovaSeq Sales Growth
There was plenty to like when Illumina (NASDAQ: ILMN) reported its second-quarter results in August. Pretty much everything that could go right has gone right for the gene-sequencing leader.....
Illumina Inc. Keeps Up Its Winning Ways Thanks to NovaSeq Sales Growth
There was plenty to like when Illumina (NASDAQ: ILMN) reported its second-quarter results in August. Pretty much everything that could go right has gone right for the gene-sequencing leader.....
Illumina Inc. Keeps Up Its Winning Ways Thanks to NovaSeq Sales Growth
There was plenty to like when Illumina (NASDAQ: ILMN) reported its second-quarter results in August. Pretty much everything that could go right has gone right for the gene-sequencing leader.....
3 Value Stocks for Retirement
Retirement marks the crowning achievement of a lifetime of hard work and frugal saving. However, it does not mark the end of a marathon, as many believe. It merely marks the beginning of what will....
3 Value Stocks for Retirement
Retirement marks the crowning achievement of a lifetime of hard work and frugal saving. However, it does not mark the end of a marathon, as many believe. It merely marks the beginning of what will....
Why Ionis Pharmaceuticals Inc. Slipped This Morning
Shares of Ionis Pharmaceuticals Inc. (NASDAQ: IONS) dipped 13% lower in early morning trading on Tuesday after its most important collaboration partner reported some disturbing third-quarter sales....
Why Ionis Pharmaceuticals Inc. Slipped This Morning
Shares of Ionis Pharmaceuticals Inc. (NASDAQ: IONS) dipped 13% lower in early morning trading on Tuesday after its most important collaboration partner reported some disturbing third-quarter sales....
Why Ionis Pharmaceuticals Inc. Slipped This Morning
Shares of Ionis Pharmaceuticals Inc. (NASDAQ: IONS) dipped 13% lower in early morning trading on Tuesday after its most important collaboration partner reported some disturbing third-quarter sales....
3 Top Biotech Stocks to Buy Now
You should seriously consider adding a few biotech stocks to your portfolio if you don't already own some. Why? Because they give you an opportunity to make higher returns.And the good news is....
In Case You Missed It, Johnson & Johnson Is Undergoing a Major Business Transformation
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) is what you might call a staple stock. It's a common holding for growth, value, and income investors given that many of the products it....
In Case You Missed It, Johnson & Johnson Is Undergoing a Major Business Transformation
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) is what you might call a staple stock. It's a common holding for growth, value, and income investors given that many of the products it....
Better Buy: Gilead Sciences, Inc. vs. Amgen
Amgen (NASDAQ: AMGN) and Gilead Sciences (NASDAQ: GILD) are central figures within the biotech landscape. However, these two titans of the industry are both in the process of refreshing their....
Better Buy: Gilead Sciences, Inc. vs. Amgen
Amgen (NASDAQ: AMGN) and Gilead Sciences (NASDAQ: GILD) are central figures within the biotech landscape. However, these two titans of the industry are both in the process of refreshing their....
Better Buy: Gilead Sciences, Inc. vs. Amgen
Amgen (NASDAQ: AMGN) and Gilead Sciences (NASDAQ: GILD) are central figures within the biotech landscape. However, these two titans of the industry are both in the process of refreshing their....
3 Small, Profitable Biotechs With Fantastic Growth
Investors could be forgiven for shying away from the stocks of small biotechs. Not only is the complex technology behind their products almost impossible for most of us to understand, the majority....
Why Exactech Skyrocketed 31% Today
After agreeing to be taken private by global alternative asset manager TPG Capital, Exactech (NASDAQ: EXAC) jumped 31% today.Exactech makes orthopedic implant devices and related surgical....
Why Exactech Skyrocketed 31% Today
After agreeing to be taken private by global alternative asset manager TPG Capital, Exactech (NASDAQ: EXAC) jumped 31% today.Exactech makes orthopedic implant devices and related surgical....
Why MiMedx Group Inc. Is Sinking Today
Shares of MiMedx Group (NASDAQ: MDXG), a biopharmaceutical company focused on regenerative medicine, fell 10% as of 3:45 p.m. EDT on Monday. However, there doesn't appear to be any....
Why DBV Technologies SA Plummeted and Aimmune Therapeutics Inc Skyrocketed Today
DBV Technologies (NASDAQ: DBVT) is down 45% at 12:48 p.m. EDT after announcing that its peanut allergy treatment, Viaskin Peanut, failed -- albeit not by much -- a phase 3 trial. The results....
Why Agenus Inc. Stock Briefly Popped Today
Agenus (NASDAQ: AGEN), a clinical-stage cancer immunotherapy company, saw its shares open up 13% higher Monday on trading volumes nearly six times the daily average. The move came in response to....
A Foolish Take: The Best-Performing S&P 500 Stock This Year
It has been a good year so far for stocks, with the S&P 500 up 15% since the beginning of 2017. But that's just an average of the 500 stocks on the large-cap index; some have done even....
A Foolish Take: The Best-Performing S&P 500 Stock This Year
It has been a good year so far for stocks, with the S&P 500 up 15% since the beginning of 2017. But that's just an average of the 500 stocks on the large-cap index; some have done even....
A Foolish Take: The Best-Performing S&P 500 Stock This Year
It has been a good year so far for stocks, with the S&P 500 up 15% since the beginning of 2017. But that's just an average of the 500 stocks on the large-cap index; some have done even....
3 Gene Therapy Stocks That Could Make You Rich
The FDA just approved another gene-altering cancer treatment that will save thousands of lives. Yescarta from Gilead Sciences (NASDAQ: GILD) teaches cancer patients' immune cells to seek out and....